Cormac Sheridan[email protected]Molecular ImagingWMIC: Molecular imaging cries out for better toolsMultiscale imaging of the angiogenic network is uncovering new insights into tumor biology and challenging accepted anatomical models, but better tools -- both qualitative and validated -- are vital for multiparametric high-resolution mapping of structural, functional, cellular, and molecular imaging, according to a speaker at the World Molecular Imaging Congress (WMIC).September 12, 2012Molecular ImagingWMIC: Imaging remains 'poor relation' in research circlesDUBLIN - In funding terms, imaging research is still the poor relation and will remain so until there is more collaboration and the field acts in a concerted way to validate and standardize methods and technologies to support clinical translation, said a speaker at the World Molecular Imaging Congress (WMIC).September 9, 2012Molecular ImagingWMIC: Landscape changes for coronary artery disease casesDUBLIN - The management of patients with chronic coronary artery disease is moving rapidly from simple diagnosis to guidance of therapy and the prevention of future cardiac events, a Finnish researcher told delegates at the World Molecular Imaging Congress (WMIC).September 6, 2012Molecular ImagingWMIC: MRI-HIFU prepares to enter clinical arenaDUBLIN - The combination of MRI with high-intensity focused ultrasound (HIFU) results in a noninvasive technique that precisely targets finely controlled amounts of energy to defined locations and is gaining acceptance, delegates learned today at the World Molecular Imaging Congress (WMIC).September 4, 2012Page 1 of 1Top StoriesMolecular ImagingF-18 PSMA PET-CT proves clinical value in prostate cancerF-18 prostate-specific membrane antigen (PSMA) PET/CT is having a major impact on patient care and therapy decisions in prostate cancer, but it’s crucial to bear in mind the modality’s diagnostic quirks.Molecular ImagingCombined PET scans predict progression of Alzheimer’sMolecular ImagingPET scans predict outcomes for patients undergoing CAR T-cell therapyMRIMRI-based nomogram provides boost in breast cancerCTCT estimated to cause 5% of new cancer cases